AEON Biopharma, Inc. AEON
0.18 USD 0.00 (-1.38%)
At closeNov 10, 2026, 7:58 PM EST
0.18 +0.01 +3.07%
After hours · Nov 10, 7:58 PM ET
0.1712 Day range 0.1835
0.127 52-week range 1.45
- YTD
- -83.70%
- 1 year
- -80.82%
News
thenewswire.com Aeon Strategies Ltd. Provides Bi-Weekly MCTO Status Update TORONTO, ONTARIO – TheNewswire - November 10, 2026 (The Newswire) – AEON STRATEGIES LTD. (formerly Cloud3 Ventures Inc.) (CSE: AEON) (OTCQB: CLDVF) (FSE: WQ40) (the “ Company ” or “ Aeon ”) is…
benzinga.com AEON Biopharma Submits IND To FDA For Comparative Pharmacodynamic Study Of ABP-450 Submission advances ABP-450 biosimilar development program following recent FDA Type 2b meetingPlanned CMAP study designed to generate clinical evidence comparing the neuromuscular activity of…
globenewswire.com AEON Biopharma Submits IND for Comparative Pharmacodynamic Study of ABP-450 Submission advances ABP-450 biosimilar development program following recent FDA Type 2b meeting
thenewswire.com AEON STRATEGIES LTD. Provides Update on Anticipated Late Filing of Annual Financial Statements TORONTO, ONTARIO – TheNewswire - October 27, 2026 — AEON STRATEGIES LTD. (formerly Cloud3 Ventures Inc.) (CSE: AEON) (OTCQB: CLDVF) (FSE: WQ40) (the “ Company ” or “ Aeon ”) provides an update to its…
thenewswire.com Aeon Strategies Ltd. Announces Anticipated Late Filing of Annual Financial Statements and Application for Management Cease Trade Order TORONTO, ONTARIO – TheNewswire - October 23, 202 6 - AEON STRATEGIES LTD. (formerly Cloud3 Ventures Inc.) (CSE: AEON) (OTCQB:CLDVF)(FSE:WQ40) (the “ Company ” or “ Aeon ”) announces that it expects…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's after-market session. The market value of their outstanding shares is at $276.0 million. Stablecoin…
benzinga.com Apple To $355? Here Are 10 Top Analyst Forecasts For Thursday Analysts raised targets for HPE, Phillips 66, Micron and AEON; cut targets for Liquidia, Apple and Zions.
benzinga.com Lake Street Maintains Buy on AEON Biopharma, Raises Price Target to $2 Lake Street analyst Thomas Flaten maintains AEON Biopharma (AMEX:AEON) with a Buy and raises the price target from $1 to $2.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday's regular session. Tenon Medical (NASDAQ:TNON) stock increased by 47.25% to $4.02. The market value of…
globenewswire.com AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450 FDA indicated previously completed ABP-450 head-to-head studies versus BOTOX® may be submitted as supportive evidence; AEON expects to advance the required scientific bridging work AEON plans to…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 110.6% to $1.39 during Friday's regular session. Tenon Medical (NASDAQ:TNON) shares rose 69.71% to $8.99. The company's market cap…
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after-market session. The company's market cap stands at $11.5 million. Picard Medical (AMEX:PMI) stock moved…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 76.4% to $4.3 during Thursday's regular session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON)…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre-market session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma…
benzinga.com Why AeroVironment Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket AeroVironment surged 5.8% premarket after beating Q1 revenue and EPS estimates; Synergy CHC led gainers, while Ribbon Acquisition fell.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market session. The market value of their outstanding shares is at $58.5 million. AEON Biopharma (AMEX:AEON)…
globenewswire.com AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX® ABP-450 and BOTOX® demonstrated comparable rates of potency loss under thermal stress and similar site-specific oxidation patterns across methionine sites evaluated Results provide additional…
globenewswire.com AEON Biopharma to Participate in Lake Street Capital Markets' 10th Annual Best Ideas Growth (BIG10) Conference ALISO VIEJO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX®…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million. Propanc Biopharma (NASDAQ:PPCB) stock…
- benzinga.com AEON Biopharma Designates Paul Lee As Chief Regulatory Office AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S.
globenewswire.com AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer - Former Deputy Director of the FDA's Office of Neuroscience - Dr. Lee has previously advised AEON through Clintrex Research LLC (Clintrex), an affiliate of BlueRidge Life Sciences, on the regulatory…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.6 million. As per the news, the Q2…
benzinga.com AEON Biopharma Announces Final, Expanded Primary Structure Results And Preliminary Disulfide Bond Characterization Data Providing Complementary Evidence Supporting Molecular Similarity Of ABP-450 To BOTOX - Complementary peptide-mapping methods increased coverage of the active botulinum neurotoxin primary sequence from approximately 93% to 98%, with 100% amino acid identity across all regions analyzed…
globenewswire.com AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - Complementary peptide-mapping methods increased coverage of the active botulinum neurotoxin primary sequence from approximately 93% to 98%, with 100% amino acid identity across all regions analyzed- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's after-market session. The company's market cap stands at $4.9 million. Quanterix (NASDAQ:QTRX) shares…
benzinga.com HC Wainwright & Co. Maintains Buy on AEON Biopharma, Lowers Price Target to $1.2 HC Wainwright & Co. analyst Douglas Tsao maintains AEON Biopharma (AMEX:AEON) with a Buy and lowers the price target from $5 to $1.2.
benzinga.com AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) Estimate AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.67 percent increase over losses of…
globenewswire.com AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Executed a $15.3 million financing with milestone warrants providing potential for an additional $34.0 million in gross proceeds, supporting continued advancement of ABP-450's development program- benzinga.com AEON Biopharma Regains NYSE American Compliance AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S.
globenewswire.com AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards ALISO VIEJO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX®…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock…
globenewswire.com Bitget Launchpool adds AEON (AEON) with 1.1M in Token Rewards VICTORIA, Seychelles, July 27, 2026 (GLOBE NEWSWIRE) -- Bitget , the world's largest Universal Exchange (UEX), announced the addition of AEON (AEON) to Bitget Launchpool and spot market. Spot trading…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday's regular session. The market value of their outstanding shares is at $24.9 million. Conexeu Sciences…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.0 million. Catheter Precision…
benzinga.com Why Aehr Test Systems Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test Systems beats Q4 estimates and issues FY27 guidance above estimates.
globenewswire.com AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding $13.75 million underwritten public offering with up to an additional $29.6 million in potential proceeds tied to the cash exercise in full of the milestone warrants issued in the offering $13.75…
benzinga.com Why Vision Marine Technologies Shares Are Trading Higher By Over 60%; Here Are 20 Stocks Moving Premarket Vision Marine Technologies Inc (NASDAQ: VMAR) gained 60.3% to $2.26 in pre-market trading after reporting third-quarter financial results with 27% jump in revenue. Other gainers and losers also…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million. Forte Biosciences…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's pre-market session. The company's market cap stands at $2.5 million. Alnylam Pharmaceuticals…
- benzinga.com AEON Biopharma Presents New Analytical And Functional Data Supporting Biosimilarity Of ABP-450 To BOTOX At 68th Annual Scientific Meeting Of AHS AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S.…
globenewswire.com AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX®…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
globenewswire.com AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - Reported positive FDA Type 2a meeting supporting ABP-450's comparative analytical strategy under the 351(k) regulatory pathway - - Strengthened balance sheet through financing transactions and…
globenewswire.com AEON Biopharma Sets Annual Shareholder Meeting - Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif. , April 24, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE American: AEON), a…
defenseworld.net Aerovate Therapeutics (NASDAQ:AVTE) & AEON Biopharma (NASDAQ:AEON) Head to Head Survey Aerovate Therapeutics (NASDAQ: AVTE - Get Free Report) and AEON Biopharma (NASDAQ: AEON - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast…
globenewswire.com AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a…
globenewswire.com AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session